Profound Medical Corp. financial data

Symbol
PROF on Nasdaq
Location
Mississauga, Ontario, Canada
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 837% %
Quick Ratio 117% %
Debt-to-equity 22% %
Return On Equity -90% % -42%
Return On Assets -74% %
Operating Margin -256% % 17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36,293,640 shares 21%
Common Stock, Shares, Outstanding 36,293,640 shares 21%
Common Stock, Value, Issued $323,839,000 USD 15%
Weighted Average Number of Shares Outstanding, Basic 30,232,966 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 30,232,966 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $16,098,000 USD 51%
Revenue from Contract with Customer, Excluding Assessed Tax $13,407,000 USD 99%
Cost of Revenue $4,705,000 USD 29%
Research and Development Expense $20,596,000 USD 21%
Operating Income (Loss) $41,254,000 USD -25%
Nonoperating Income (Expense) $1,064,000 USD -120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $42,318,000 USD -52%
Income Tax Expense (Benefit) $252,000 USD
Net Income (Loss) Attributable to Parent $42,570,000 USD -53%
Earnings Per Share, Basic 1.41 USD/shares 26%
Earnings Per Share, Diluted 1.41 USD/shares 26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $59,723,000 USD 8.8%
Inventory, Net $8,238,000 USD 42%
Assets, Current $76,089,000 USD 10%
Deferred Income Tax Assets, Net $66,000 USD -24%
Property, Plant and Equipment, Net $698,000 USD 64%
Operating Lease, Right-of-Use Asset $184,000 USD -54%
Assets $77,475,000 USD 10%
Accounts Payable, Current $1,563,000 USD 19%
Employee-related Liabilities, Current $2,347,000 USD 232%
Liabilities, Current $6,075,000 USD -7.5%
Contract with Customer, Liability, Noncurrent $388,000 USD 692%
Other Liabilities, Noncurrent $79,000 USD 11%
Liabilities $11,041,000 USD 13%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,025,000 USD 83%
Retained Earnings (Accumulated Deficit) $287,740,000 USD -17%
Stockholders' Equity Attributable to Parent $66,434,000 USD 10%
Liabilities and Equity $77,475,000 USD 10%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 36,293,640 shares 21%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59,723,000 USD 8.8%
Deferred Tax Assets, Valuation Allowance $63,397,000 USD 18%
Deferred Tax Assets, Gross $63,463,000 USD 18%
Operating Lease, Liability $213,000 USD -54%
Depreciation $373,000 USD -47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $40,287,000 USD -31%
Lessee, Operating Lease, Liability, to be Paid $216,000 USD -55%
Property, Plant and Equipment, Gross $2,289,000 USD -19%
Operating Lease, Liability, Current $213,000 USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year One $216,000 USD -21%
Operating Lease, Weighted Average Discount Rate, Percent 0.0599 pure 0%
Deferred Income Tax Expense (Benefit) $21,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,000 USD -85%
Deferred Tax Assets, Operating Loss Carryforwards $52,152,000 USD 21%
Current Income Tax Expense (Benefit) $231,000 USD 60%
Additional Paid in Capital $25,310,000 USD 19%
Deferred Tax Assets, Net of Valuation Allowance $66,000 USD -24%
Share-based Payment Arrangement, Expense $5,490,000 USD 113%